Additional file 1: Table S1. of Rituximab plus chemotherapy as first-line treatment in Chinese patients with diffuse large B-cell lymphoma in routine practice: a prospective, multicentre, non-interventional study

Baseline characteristics. Table S2. Comparisons of baseline characteristics between patients with history of heart or liver diseases and patients without heart or liver diseases. Table S3. Summary of AEs. Table S4. Summary of hepatic AEs. Table S5. Summary of cardiovascular AEs. Table S6. Summary of screening results of DLBCL patients prior to DLBCL treatment. Table S7 Comparisons of baseline characteristics between HBsAg-pos or HBsAg-neg/HBcAb-pos patients with double-neg patients. Figure S1. HBV DNA testing prior to R-chemo. Figure S2. HBV infection monitoring in R-chemo treated DLBCL patients. (DOCX 276 kb

Additional file 1: of Chidamide in relapsed or refractory peripheral T cell lymphoma: a multicenter real-world study in China

Methods (DOCX 16 kb

Additional file 2: Table S1. of Chidamide in relapsed or refractory peripheral T cell lymphoma: a multicenter real-world study in China

Patients’ baseline characteristics (DOCX 16 kb